跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 90,070 条关于
“AOP Health US”
全部
90,070
临床试验
67,662
药物
1,025
机构
2,518
资讯
18,865
5个月前
FDA Approves Rapiblyk for Pediatric Supraventricular Tachycardia, Marking First U.S. Treatment Option
去年
RHEACELL and AOP Health Partner to Advance Stem Cell Therapy for Epidermolysis Bullosa and Chronic Venous Wounds
9个月前
AOP Health Presents New Clinical Data for Ropeginterferon Alfa-2b in Rare Blood Cancers at ASH 2025
去年
ICC Tribunal Rules in AOP Health's Favor Over BESREMi Licensing Dispute with PharmaEssentia
4个月前
Frankfurt Court Upholds Arbitral Award Securing BESREMi Access for Polycythemia Vera Patients
去年
FDA Approves Rapiblyk (landiolol) for Supraventricular Tachycardia
去年
FDA Approves AOP Health's Rapiblyk (Landiolol) for Supraventricular Tachycardia in Critical Care
去年
US Health Sector Advances in Regulatory Measures and Pharmaceutical Innovations
9个月前
Shield Therapeutics Secures FDA Approval Extension for ACCRUFeR in Pediatric Patients, Eyes China Market Entry in Q1 2026
去年
FDA Approves Landiolol (Rapiblyk) for Rapid Heart Rate Reduction in Critical Care
第 1 页,共 1887 页
上一页
下一页